Article Text

Download PDFPDF
COX-2 dependent PGE2 downregulates αv integrin expression via the EP3 receptor in cultured mesangial cells
  1. C Waldner1,
  2. K Schrör2,
  3. P Heering1
  1. 1Nephrologie und allgemeine Innere Medizin, Städtisches Klinikum Solingen, Gotenstraße 1, D-42653 Solingen, Germany
  2. 2Institut für Pharmakologie und Klinische Pharmakologie, Universitätsklinikum, D-40225 Düsseldorf, Germany
  1. Correspondence to:
 Professor P Heering
 Department of Medicine III, Solingen General Hospital, University of Cologne, Gotenstraße 1, D-42653 Solingen, Germany; heeringklinikumsolingen.de

Abstract

Background: In experimental glomerulonephritis, inhibition of cyclooxygenase 2 (COX-2) enhances the renocortical expression of pathogenic αv integrins.

Aims: To study whether this effect is mediated by prostaglandin E2 (PGE2) acting through its EP3 receptor in cultured rat mesangial cells (MCs).

Methods: MCs were incubated with lipopolysaccharide (LPS), celecoxib, PGE2, or the selective EP3 agonist, MB28767. The expression of COX-2, EP3, and αv integrin mRNA was measured by reverse transcriptase polymerase chain reaction.

Results: LPS upregulated COX-2 expression 2.8-fold and αv integrin expression twofold. The COX-2 inhibitor celecoxib increased αv integrin mRNA expression twofold. Both exogenous PGE2 and the specific EP3 receptor agonist, MB28767, reduced constitutive αv integrin mRNA expression to half normal values. COX-2 dependent PGE2 suppressed the expression of αv integrin mRNA mediated by the EP3 receptor in MCs.

Conclusions: These results suggest that COX-2 suppresses the expression of αv integrins by an increased production of PGE2 activating its EP3 receptor in glomerulonephritis.

  • COX-2
  • αv integrins
  • EP3 receptor
  • celecoxib
  • COX-2, cyclooxygenase 2
  • LPS, lipopolysaccharide
  • MC, mesangial cell
  • PGE2, prostaglandin E2
  • RT-PCR, reverse transcriptase polymerase chain reaction

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes